Mechanisms of hepatitis C virus NS3 proteinase inhibitors

Journal of Viral Hepatitis

Volumn 6, Issue SUPPL. 1, 1999, Pages 23-30

  De Francesco, R ^a   Pessi, A ^a   Steinkuhler C ^a  

^a IRBM   (Italy)

Author keywords

HCV; Hepatitis; NS3; NS4A; Proteinase inhibitors; Serine proteinase; Zinc

Indexed keywords

SERINE PROTEINASE INHIBITOR; VIRUS ENZYME; ZINC;

BETA CHAIN; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME CONFORMATION; ENZYME INHIBITION; HEPATITIS C VIRUS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS; STRUCTURE ANALYSIS;

BINDING SITES; ENZYME INHIBITORS; MUTAGENESIS, SITE-DIRECTED; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL NONSTRUCTURAL PROTEINS; ZINC;

EID: 0032786983     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1999.00002.x     Document Type: Article

References (51)

1. Houghton M. Hepatitis C viruses. In: Fields BN, Knipe DM, Howley PM (eds). Fields' Virology, 3rd edn. Philadelphia, New York, Lippincott-Raven, 1996: 1035-1058.
2. Hoofnagle JH. Hepatitis C. the clinical spectrum of disease. Hepatol 1997; 26 (Suppl. 1): 15S-20S.
3. Alberti A, Realdi G. Parentally acquired non-A, non-B (type C) hepatitis. In: McIntyre N, Benhamou J-P, Bircher J, Rizzetto M, Rodes J (eds). Oxford Textbook of Clinical Hepatology. Oxford, Oxford University Press, 1991.
4. Lindsay KL. Therapy of hepatitis C. Overview Hepatol 1997; 26 (Suppl. 1): 71S-77S.
5. Major ME, Feinstone SM. The molecular virology of hepatitis C. Hepatol 1997; 25: 1527-1538.
6. Francki RIB, Fauquet CM, Knudson DL, Brown F. Classification and nomenclature of viruses: fifth report of the International Committe on Taxonomy of Viruses. Arch Virol Supplement 1991; 2: 223-233.
7. Lohman V, Koch JO, Bartenschlager R. Processing pathways of the hepatitis C virus proteins. J Hepatol 1996; 24 (Suppl. 2): 11-19.
8. Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice CM. A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci USA 1993; 90: 10583-10587.
9. Hijikata M, Mizushima H, Akagi T et al. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol 1993; 67: 4665-1675.
10. Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice C. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol 1993; 67: 2832-2843.
11. Tomei L, Failla C, Santolini E, De Francesco R, La Monica N. NS3 is a serine proteinase required for processing of hepatitis C virus polyprotein. J Virol 1993; 67: 4017-4026.
12. Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H. Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol 1993; 67: 3835-3844.
13. Eckart MR, Selby M, Masiarz F et al. The hepatitis C virus encodes a serine proteinase involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun 1993; 192: 399-406.
14. Manabe S, Fuke I, Tanishita O et al. Production of nonstructural proteins of hepatitis C virus requires a putative viral proteinase encoded by NS3. Virol 1994; 198: 636-644.
15. D'Souza EDA, O'Sullivan E, Amphlett EM et al. Analysis of NS3-mediated processing of the hepatitis C virus non-structural region in vitro. J Gen Virol 1994; 75: 3469-3476.
16. Failla C, Tomei L, De Francesco R. An amino-terminal domain of the hepatitis C virus NS3 proteinase is essential for interaction with NS4A. J Virol 1995; 69: 1769-1777.
17. Bartenschlager R, Lohman V, Wilkinson T, Koch JO. Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. J Virol 1995; 69: 7519-7528.
18. Lin C, Thomson JA, Rice CM. A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro. J Virol 1995; 69: 4373-4380.
19. Failla C, Tomei L, De Francesco R. Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J Virol 1994; 68: 3753-3760.
20. Lin C, Pragai BM, Grakoui A, Xu J, Rice CM. Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J Virol 1994; 68: 8147-8157.
21. Bartenschlager R, Ahlborn Laake L, Mous J, Jacobsen H. Kinetic and structural analyses of hepatitis C virus polyprotein processing. J Virol 1994; 68: 5045-5055.
22. Tanji Y, Hijikata M, Satoh S, Kaneko T, Shimotohno K. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J Virol 1995; 69: 1575-1581.
23. Shimizu Y, Yamaji K, Masuho Y et al. Identification of the sequence of NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 proteinase. J Virol 1996; 70: 127-132.
24. Tomei L, Failla C, Vitale RL, Bianchi E, De Francesco R. A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 proteinase. J Gen Virol 1996; 77: 1065-1070.
25. Koch JO, Lohmann V, Herian U, Bartenschlager R. In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor. Virol 1996; 221: 54-66.
26. Steinkühler C, Urbani A, Tomei L et al. Activity of purified hepatitis C virus proteinase NS3 on peptide substrates. J Virol 1996; 70: 6694-6700.
27. Butkiewicz NJ, Wendel M, Zhang R et al. Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity. Virol 1996; 225: 328-338.
28. Hahm B, Han DS, Back SH et al. NS3-4A of hepatitis C virus is a chymotrypsin-like proteinase. J Virol 1995; 69: 2534-2539.
29. Han DS, Hahm B, Rho HM, Jang SK. Identification of the serine proteinase domain in NS3 of the hepatitis C virus. J Gen Virol 1995; 76: 985-993.
30. Tanji Y, Hijikata M, Hirowatari Y, Shimotohno K. Identification of the domain required for trans-cleavage activity of hepatitis C viral serine proteinase. Gene 1994; 145: 215-219.
31. Steinkühler C, Tomei L, De Francesco R. In vitro activity of hepatitis C virus proteinase NS3 purified from recombinant baculovirus-infected Sf9 cells. J Biol Chem 1996; 271: 6367-6373.
32. Landro JA, Raybuck SA, Luong YPC et al. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 proteinase of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping. Biochem 1997; 36: 9340-9348.
33. Bianchi E, Urbani A, Biasiol G et al. Complex formation between the hepatitis C virus serine proteinase and a synthetic NS4A cofactor peptide. Biochem 1997; 36: 7890-7897.
34. Vishnuvardan D, Kakiuchi N, Urvil PT et al. Expression of highly active recombinant NS3 proteinase domain of hepatitis C virus in E. coli. FEBS Lett 1997; 402: 209-212.
35. Kim JL, Morgenstern KA, Lin C et al. Crystal structure of the hepatitis virus NS3 proteinase domain complexed with a syntehtic NS4A cofactor peptide. Cell 1996; 87: 343-355.
36. Yan Y, Li Y, Munshi S et al. Complex of NS3 proteinase and NS4A peptide of BK strain hepatitis C virus: a 2.2 Å resolution structure in a hexagonal crystal form. Protein Sci 1998; 7: 837-847.
37. Lesk AM, Fordham WD. Conservation and variability in the structure of serine proteinases of the chymotrypsin family. J Mol Biol 1996; 258: 501-537.
38. Love RA, Parge HE, Wickersham JA et al. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 1996; 87: 331-342.
39. Satoh S, Tanji Y, Hijikata M, Kimura K, Shimotohno K. The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A. J Virol 1995; 69: 4255-4260.
40. Love R. The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactor. Clin Virol 1998: 10: 151-156.
41. Urbani A, Bazzo R, Nardi MC et al. The metal binding site of the hepatitis C virus NS3 proteinase. A spectroscopic investigation. J Biol Chem 1998; 273: 18760-18769.
42. Rice WG, Supko JG, Malspeis L et al. Inhibitors of HIV nucleocapside protein zinc fingers as candidates for the the treatment of AIDS. Sci 1995; 270: 1194-1196.
43. Pizzi E, Tramontano A, Tomei L et al. Molecular model of the specificity pocket of the hepatitis C virus proteinase: implications for substrate recognition. Proc Natl Acad Sci USA 1994; 91: 888-892.
44. Failla C, Pizzi E, De Francesco R, Tramontano A. Redesigning the substrate specificity of the hepatitis C virus proteinase. Folding Design 1996; 1: 35-42.
45. Kolykhalov AA, Agapov EV, Rice CM. Specificity of the hepatitis C virus NS3 serine proteinase: effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing. J Virol 1994; 68: 7525-7533.
46. Tanji Y, Hijikata M, Hirowatari Y, Shimotohno K. Hepatitis C virus polyprotein processing: kinetics and mutagenic analysis of serine proteinase-dependent cleavage. J Virol 1994; 86: 8418-8422.
47. Leinbach SS, Bhat RA, Xia SM et al. Substrate specificity of the NS3 serine proteinase of hepatitis C virus as determined by mutagenesis at the NS3/NS4A junction. Virol 1994; 204: 163-169.
48. Bartenschlager R, Lohman V, Wilkinson T, Koch JO. Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. J Virol 1995; 69: 7519-7528.
49. Ingallinella P, Altamura S, Bianchi E et al. Potent peptide inhibitors of human hepatitis C virus NS3 proteinase are obtained by optimising the clevage products. Biochem 1998; 37: 8906-8914.
50. Steinkühler C, Biasiol G, Brunetti M et al. Product inhibition of the hepatitis C virus NS3 proteinase. Biochem 1998; 37: 8899-8905.
51. Wu Z, Yao N, Le HV, Weber PC. Mechanism of autoproteolysis at the NS2-NS3 junction of the hepatitis C virus polyprotein. Trends Biochem Sci 1998; 23: 92-94.